Use of likelihood ratios improves interpretation of laboratory testing for pulmonary sarcoidosis

American Journal of Clinical Pathology

Volumn 134, Issue 6, 2010, Pages 939-947

  De Smet, Dieter ^a   Martens, Geert A ^a   Vanden Berghe, Bram ^a   Meysman, Marc ^a   Heylen, Olivier ^a   Gorus, Frans K ^a   De Waele, Marc ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Angiotensin converting enzyme; Bronchoalveolar lavage fluid; CD4 CD8 ratio; Diagnosis; Likelihood ratio; Pulmonary sarcoidosis

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ALGORITHM; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME BLOOD LEVEL; FEMALE; FLOW CYTOMETRY; HUMAN; LABORATORY TEST; LOGISTIC REGRESSION ANALYSIS; LUNG LAVAGE; LUNG SARCOIDOSIS; LYMPHOCYTE COUNT; MALE; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; STATISTICAL MODEL;

ALGORITHMS; BRONCHOALVEOLAR LAVAGE FLUID; CD4-CD8 RATIO; CLINICAL LABORATORY TECHNIQUES; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; LIKELIHOOD FUNCTIONS; LOGISTIC MODELS; MALE; RETROSPECTIVE STUDIES; SARCOIDOSIS, PULMONARY;

EID: 78649668013     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPNC7STHG0FWMP     Document Type: Article

References (25)

1. Hunninghake GW, Costabel U, Ando M, et al. ATS/ERS/ WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis. 1999;16:149-173.
2. Baughman RP, Lower EE, du Bois RM. Sarcoidosis. Lancet. 2003;361:1111-1118.
3. Henke CE, Henke G, Elveback R, et al. The epidemiology of sarcoidosis in Rochester, Minnesota: a population-based study of incidence and survival. Am J Epidemiol. 1986;123:840-845.
4. Hillerdal G, Nöu E, Osterman K, et al. Sarcoidosis: epidemiology and prognosis: a 15-year European study. Am Rev Respir Dis. 1984;130:29-32.
5. Thomas KW, Hunninghake GW. Sarcoidosis. JAMA. 2003;289:3300-3303.
6. Rybicki BA, Major M, Popovich J Jr, et al. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol. 1997;145:234-241.
7. Heron M, Slieker WA, Zanen P, et al. Evaluation of CD103 as a cellular marker for the diagnosis of pulmonary sarcoidosis. Clin Immunol. 2008;126:338-344.
8. Judson MA, Thompson BW, Rabin DL, et al. The diagnostic pathway to sarcoidosis. Chest. 2003;123:406-412.
9. Bunting PS, Szalai JP, Katic M. Diagnostic aspects of angiotensin converting enzyme in pulmonary sarcoidosis. Clin Biochem. 1987;20:213-219.
10. Rothkrantz-Kos S, Van Dieijen-Visser MP, Mulder PG, et al. Potential usefulness of inflammatory markers to monitor respiratory functional impairment in sarcoidosis. Clin Chem. 2003;49:1510-1517.
11. Kolopp-Sarda MN, Kohler C, De March AK, et al. Discriminative immunophenotype of bronchoalveolar lavage CD4 lymphocytes in sarcoidosis. Lab Invest. 2000;80:1065-1069.
12. Maruchella A, Tondini M. Reliability of bronchoalveolar lavage in the routine clinical assessment of patients with sarcoidosis: a retrospective analysis. Panminerva Med. 2002;44:257-260.
13. Fischer JE, Bachmann LM, Jaeschke R. A readers' guide to the interpretation of diagnostic test properties: clinical example of sepsis. Intensive Care Med. 2003;29:1043-1051.
14. Bossuyt X. Clinical performance characteristics of a laboratory test: a practical approach in the autoimmune laboratory. Autoimmun Rev. 2009;8:543-548.
15. Pauker SG, Kopelman RI. Interpreting hoofbeats: can Bayes help clear the haze? N Engl J Med. 1992;327:1009-1013.
16. Pauker SG, Kassirer JP. The threshold approach to clinical decision making. N Engl J Med. 1980;302:1109-1117.
17. Fagan TJ. Letter: nomogram for Bayes theorem. N Engl J Med. 1975;293:257.
18. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837-845.
19. Simel DL, Samsa GP, Matchar DB. Likelihood ratios with confidence: sample size estimation for diagnostic test studies. J Clin Epidemiol. 1991;44:763-770.
20. Gilman MJ, Wang KP. Transbronchial lung biopsy in sarcoidosis: an approach to determine the optimal number of biopsies. Am Rev Respir Dis. 1980;122:721-724.
21. Poe RH, Israel RH, Utell MJ, et al. Probability of a positive transbronchial lung biopsy result in sarcoidosis. Arch Intern Med. 1979;139:761-763.
22. Trisolini R, Lazzari Agli L, Cancellieri A, et al. Transbronchial needle aspiration improves the diagnostic yield of bronchoscopy in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2004;21:147-151.
23. Zwischenberger JB, Savage C, Alpard SK, et al. Mediastinal transthoracic needle and core lymph node biopsy: should it replace mediastinoscopy? Chest. 2002;121:1165-1170. (Pubitemid 34280438)
24. Tournoy KG, Bolly A, Aerts JG, et al. The value of endoscopic ultrasound after bronchoscopy to diagnose thoracic sarcoidosis [published online ahead of print November 6, 2009]. Eur Respir J. 2010;35:1329-1335.
25. Grutters JC, Fellrath J-M, Mulder L, et al. Serum sIL2R measurement in sarcoidosis patients: a clinical evaluation. Chest. 2003;124:186-195.